StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

BESTBullishAnalyst Target Updateanalyst
Medium materiality6/10

H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)

Sep 8, 2026, 2:41 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Reaffirmed Buy with meaningful upside versus current price.

AI summary

What happened, with direct paths to the underlying reporting

Opus Genetics target $8; posted price $2.78; Buy rating reiterated.

  • Wainwright reiterates Buy; PT $8; price $2.78

Key facts

  1. 01

    Target: $8

  2. 02

    Posted price: $2.78

  3. 03

    Analyst firm: H.C. Wainwright

  4. 04

    Analyst: Matthew Caufield

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.